Sildenafil — evidence-based review (for educational purposes only)

Disclaimer: This article is for informational and educational purposes. It does not replace medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting or changing any medication.

Quick summary

• Sildenafil is a prescription medicine most commonly used for erectile dysfunction (ED) and pulmonary arterial hypertension (PAH).
• It works by increasing blood flow through inhibition of the enzyme phosphodiesterase type 5 (PDE5).
• Strong evidence supports its effectiveness for ED; evidence is also solid for PAH under specialist care.
• Common side effects include headache, flushing, nasal congestion, and indigestion; serious side effects are rare but possible.
• It must not be used with nitrates and requires caution in people with heart disease.

What is known

1. Mechanism of action (how sildenafil works)

Sildenafil belongs to a class of drugs called PDE5 inhibitors. It blocks the enzyme phosphodiesterase type 5, which normally breaks down cyclic guanosine monophosphate (cGMP). By preserving cGMP levels, sildenafil enhances the natural process of blood vessel relaxation. In erectile tissue, this increases blood flow in response to sexual stimulation. In the lungs (for PAH), it helps relax pulmonary blood vessels and reduce pressure.

This mechanism is well established in pharmacology and supported by laboratory and clinical research.

2. Effectiveness for erectile dysfunction (ED)

Multiple randomized controlled trials and meta-analyses show that sildenafil significantly improves erectile function compared with placebo. Benefits include:

• Improved ability to achieve and maintain an erection.
• Improved sexual satisfaction scores.
• Effectiveness across various causes of ED, including diabetes and post-prostate surgery (though response rates may vary).

Major guidelines, such as those from the American Urological Association (AUA) and the European Association of Urology (EAU), list PDE5 inhibitors like sildenafil as first-line therapy for many men with ED, unless contraindicated.

3. Use in pulmonary arterial hypertension (PAH)

Sildenafil is also approved for pulmonary arterial hypertension, a serious condition characterized by high blood pressure in the arteries of the lungs. In PAH, it can:

• Improve exercise capacity.
• Delay clinical worsening in some patients.
• Improve certain hemodynamic measurements.

Its use in PAH is typically managed by specialists in cardiology or pulmonology.

4. Safety profile and common side effects

Most side effects are mild to moderate and temporary. Commonly reported effects include:

• Headache
• Facial flushing
• Nasal congestion
• Indigestion (dyspepsia)
• Visual disturbances (such as a blue tinge or increased light sensitivity)

Rare but serious adverse events may include sudden hearing loss, priapism (a prolonged erection lasting more than 4 hours), severe hypotension, or cardiovascular events. A direct causal link to heart attacks is not clearly established; sexual activity itself increases cardiac workload, which may explain some reported events.

5. Contraindications and drug interactions

One of the most important safety concerns is the interaction with nitrates (such as nitroglycerin or isosorbide). Combining nitrates with sildenafil can cause a dangerous drop in blood pressure. It is also used with caution in people who:

• Have unstable heart disease.
• Recently had a heart attack or stroke.
• Have severe liver or kidney impairment.
• Take certain alpha-blockers or other blood pressure medications.

What is unclear / where evidence is limited

• Long-term cardiovascular safety in high-risk patients: While short- and medium-term data are reassuring in many populations, evidence is more limited in very high-risk cardiac patients.
• Use in women: Research on sildenafil for female sexual dysfunction shows mixed results. It is not routinely recommended for this purpose in major guidelines.
• Recreational use in healthy individuals: Evidence does not support routine use in men without ED. Potential psychological reliance and unknown long-term effects remain concerns.
• Over-the-counter or online products: Some non-prescription products marketed as “herbal Viagra” have been found to contain undeclared sildenafil or similar compounds, posing safety risks.

Overview of approaches

Management of erectile dysfunction or pulmonary hypertension depends on the underlying cause and overall health status.

Lifestyle and risk factor management

• Regular physical activity.
• Smoking cessation.
• Weight management.
• Control of diabetes, blood pressure, and cholesterol.

These measures may improve erectile function and overall cardiovascular health.

Medication options

Sildenafil is one of several PDE5 inhibitors available by prescription. Others include tadalafil and vardenafil. Choice of agent may depend on duration of action, side-effect profile, cost, and patient preference.

Typical dosing ranges and instructions for sildenafil are described in official prescribing information from regulatory agencies such as the U.S. Food and Drug Administration (FDA):
FDA-approved prescribing information for Viagra (sildenafil). Patients should follow their clinician’s instructions and the official leaflet provided with the medication.

For readers interested in broader men’s health topics, see our men’s health guide in the Blog section and related updates in medical News.

Psychological and relationship support

For some individuals, psychological factors such as anxiety, depression, or relationship stress contribute to ED. In these cases, counseling or sex therapy may be helpful, alone or combined with medication.

Other medical or device-based options

When PDE5 inhibitors are ineffective or contraindicated, alternatives may include vacuum erection devices, injectable therapies, intraurethral medications, or surgical implants. These options require specialist evaluation.

Statement	Confidence level	Why
Sildenafil improves erectile function compared with placebo.	High	Supported by multiple randomized trials and meta-analyses; recommended in major urology guidelines.
Sildenafil is effective for pulmonary arterial hypertension.	High	Approved by regulatory agencies; supported by clinical trials in PAH populations.
Sildenafil is safe for all patients with heart disease.	Low	Contraindicated with nitrates and requires individualized cardiovascular assessment.
Sildenafil benefits women with sexual dysfunction.	Low to medium	Evidence is mixed; not routinely recommended in guidelines.

Practical recommendations

• Consult a healthcare professional before using sildenafil, especially if you have heart disease, take nitrates, or use blood pressure medications.
• Seek urgent medical attention if you experience chest pain, sudden vision or hearing loss, or an erection lasting more than 4 hours.
• Prepare for your appointment: bring a list of medications and supplements, describe your symptoms clearly (onset, severity, triggers), and mention any chronic conditions.
• Address overall health: improving cardiovascular fitness, sleep, and mental well-being may enhance treatment response.

For additional reading, explore related topics in our Post archive and curated resources in melhores-2.

Sources

• U.S. Food and Drug Administration (FDA). Prescribing information for sildenafil (Viagra/Revatio).
• American Urological Association (AUA). Guideline on the Management of Erectile Dysfunction.
• European Association of Urology (EAU). Guidelines on Sexual and Reproductive Health.
• National Institutes of Health (NIH). MedlinePlus: Sildenafil.
• European Society of Cardiology (ESC) / European Respiratory Society (ERS). Guidelines for the diagnosis and treatment of pulmonary hypertension.